ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000258334.1	ABT-263 (navitoclax)	Liver hepatocellular carcinoma	0.022734523	Sensitive
ENSG00000258334.1	ABT-263 (navitoclax)	Pancreatic adenocarcinoma	0.022334948	Sensitive